Filter
1950
Filtered Results: 1950
Text search:
mandatory
Featured
Recommendations
154
New Publications
545
Language
Document type
No document type
1095
Studies & Reports
313
Guidelines
285
Manuals
99
Strategic & Response Plan
73
Fact sheets
41
Training Material
19
Situation Updates
15
Resource Platforms
4
Infographics
4
Brochures
1
Dashboards/Maps
1
Countries / Regions
India
178
Global
67
Western and Central Europe
64
Kenya
59
South Africa
53
Ethiopia
45
Nepal
43
Sierra Leone
32
Ukraine
32
Tanzania
30
Nigeria
29
Malawi
29
Uganda
28
Ghana
27
Bangladesh
27
Rwanda
26
Myanmar / Burma
24
Latin America and the Carribbean
24
Germany
22
Zambia
22
Syria
21
Eastern Europe
21
Liberia
18
Philippines
17
Africa
17
Namibia
16
Asia
15
Indonesia
14
South–East Asia Region
14
Lesotho
13
West and Central Africa
13
East and Southern Africa
12
Colombia
11
Russia
10
Congo, Democratic Republic of
9
Botswana
9
Zimbabwe
8
Haiti
8
Mozambique
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Paraguay
8
Venezuela
8
Pakistan
7
Brazil
7
Cambodia
6
Thailand
6
Madagascar
6
Afghanistan
5
Lebanon
5
Argentina
5
Peru
5
Eswatini/ Swaziland
5
North Macedonia
5
Bolivia
5
Tajikistan
5
Georgia
5
Guinea
4
Senegal
4
South Sudan
4
Sri Lanka
4
Chile
4
Moldova
4
Jordan
3
Turkey
3
Sudan
3
Hungary
3
Ecuador
3
Yemen
3
Bhutan
3
Poland
3
Albania
3
Turkmenistan
3
United Kingdom
3
Portugal
3
Burkina Faso
2
Morocco
2
Saudi Arabia
2
Somalia
2
China
2
Ireland
2
Greece
2
Western Pacific Region
2
Fiji
2
Palestine
2
Armenia
2
Southern Africa
2
Laos
2
Timor Leste/ East Timor
2
Estonia
2
Romania
2
Iran
2
Kyrgyzstan
2
Vietnam
2
Spain
2
Mali
1
USA
1
Cameroon
1
Niger
1
Iraq
1
Mauritania
1
Benin
1
Central African Republic
1
Switzerland
1
Serbia
1
El Salvador
1
Libya
1
Angola
1
Mexico
1
North Korea
1
Italy
1
Bulgaria
1
Slovakia
1
Kazakhstan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
820
Clinical Guidelines
136
Public Health
93
Women & Child Health
79
Key Resources
75
Pharmacy & Technologies
22
Capacity Building
14
Toolboxes
HIV
201
COVID-19
187
TB
119
Mental Health
103
AMR
73
Rapid Response
62
Refugee
56
Caregiver
53
Disability
52
Planetary Health
49
Conflict
45
Ebola
41
Pharmacy
36
NTDs
34
NCDs
31
Global Health Education
29
Natural Hazards
19
Health Financing Toolbox
18
Specific Hazards
13
Zika
12
Polio
10
Cholera
9
Social Ethics
7
Health Financing
1
Unfortunately, current data available on SDG financing are not sufficient to quantify the distribution of financing for the SDGs.
AidData’s methodology for measuring financing to the SDGs attempts to fill this gap by analyzing development project documentation to estimate project-level contributi...
The majority of Countdown countries did not reach the fourth Millennium Development Goal (MDG 4) on reducing child mortality, despite the fact that donor funding to the health sector has drastically increased. When tracking aid invested in child survival, previous studies have exclusively focused on...
The thirty-seventh meeting of the Programme, Budget and Administration Committee was held in Geneva from 25 to 27 January 2023 and chaired by Ms Aishath Rishmee (Maldives). The Committee adopted its agenda and agreed its programme of work. In his opening remarks, the Director-General emphasized the ...
As a global community of +750 representatives of the world’s civil society, the C20 official Engagement Group of the G20 is submitting a list of policy priorities for the upcoming G20 Finance Ministers & Central Bank Governors meeting on July 18th and the G20 Extraordinary Sherpa Meeting on July 2...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
To provide information on trends on official development assistance (ODA) disbursement patterns for
reproductive health activities in 18 conflict-affected countries
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The guide to implementing the One Health Joint Plan of Action (OH JPA) at national level provides practical guidance on how countries can adopt and adapt the OH JPA to strengthen and support national One Health action.
Building on the OH JPA theory of change, this guide describes three pathways a...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research with human beings. This supervision includes the ac...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
